Novo Nordisk, China Count On Symbiotic Relationship For Health Care
This article was originally published in PharmAsia News
Executive Summary
Novo Nordisk's symbiotic method of doing business in China is seen as a key to the nation's effort to have a system of universal health care in place for its 1.4 billion residents by 2020.